Back
Revance Therapeutics Vs. GlycoMimetics Industry Stock Comparison
Sell
4
RVNC
Revance Therapeutics
Last Price:
4.13
Seasonality Move:
7.02%
Buy
71
GLYC
GlycoMimetics
Last Price:
0.40
Seasonality Move:
49.38%
Sell
4
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
- The current Revance Therapeutics [RVNC] share price is $3.44. The Score for RVNC is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
- RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
71
GlycoMimetics (GLYC)
is a Buy
Is GlycoMimetics a Buy, Sell or Hold?
- The current GlycoMimetics [GLYC] share price is $0.42. The Score for GLYC is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- GLYC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $3.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.
GLYC Stock Price Chart
What is GlycoMimetics's stock price today?
-
The GlycoMimetics share price today is $0.42
The current trend is moderately bullish and GLYC is experiencing slight buying pressure.
RVNC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 22.01 | Sell |
Chaikin Money Flow: | -4360846 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.71 - 5.93) | Sell |
Bollinger Bands (100): | (3.48 - 6.32) | Sell |
GLYC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 69.42 | Buy |
Chaikin Money Flow: | 2082375 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.13 - 0.39) | Buy |
Bollinger Bands (100): | (0.15 - 0.31) | Buy |
RVNC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.26 | Sell |
20-day SMA: | 5.33 | Sell |
50-day SMA: | 5.62 | Sell |
200-day SMA: | 4.66 | Sell |
8-day EMA: | 4.89 | Sell |
20-day EMA: | 5.25 | Sell |
50-day EMA: | 5.33 | Sell |
200-day EMA: | 6.2 | Sell |
GLYC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.4 | Buy |
20-day SMA: | 0.29 | Buy |
50-day SMA: | 0.21 | Buy |
200-day SMA: | 1.09 | Sell |
8-day EMA: | 0.39 | Buy |
20-day EMA: | 0.32 | Buy |
50-day EMA: | 0.26 | Buy |
200-day EMA: | 0.77 | Sell |
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.64 per share, and an increase next year of $0.63 per share.
GlycoMimetics Earnings Growth & GLYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.
Revance Therapeutics Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
GlycoMimetics Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |